Harvard Bioscience (HBIO) Interest Coverage Ratio Growth (1y) (2011 - 2019)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | -75.56% |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | - |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | -65.15% |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | - |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 35.71% |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | - |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | - |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | -36.52% |
| 10 | Harvard Bioscience | 25.38 Mn | 18.29 Mn | 12.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | -265.89% |
| Jun 30, 2019 | 164.33% |
| Mar 31, 2019 | 93.97% |
| Dec 31, 2018 | -44.97% |
| Sep 30, 2018 | 129.58% |
| Jun 30, 2018 | 82.76% |
| Mar 31, 2018 | 34.05% |
| Dec 31, 2017 | 128.52% |
| Sep 30, 2017 | 64.21% |
| Jun 30, 2017 | 67.98% |
| Mar 31, 2017 | -59.34% |
| Dec 31, 2016 | -1,414.39% |
| Sep 30, 2016 | -51.77% |
| Jun 30, 2016 | -1,113.47% |
| Mar 31, 2016 | 73.99% |
| Dec 31, 2015 | -93.81% |
| Sep 30, 2015 | -163.72% |
| Jun 30, 2015 | -93.43% |
| Mar 31, 2015 | -202.90% |
| Dec 31, 2014 | 386.42% |
| Sep 30, 2014 | 297.49% |
| Jun 30, 2014 | 130.16% |
| Mar 31, 2014 | -50.65% |
| Dec 31, 2013 | -119.94% |
| Sep 30, 2013 | -80.93% |
| Jun 30, 2013 | -81.29% |
| Mar 31, 2013 | -27.28% |
| Dec 31, 2012 | 68.65% |
| Sep 30, 2012 | 672.10% |
| Jun 30, 2012 | 24.06% |
| Mar 31, 2012 | 40.27% |
| Dec 31, 2011 | -93.36% |
| Sep 30, 2011 | -89.73% |
| Jun 30, 2011 | -28.65% |